Aras Azadian

Cannabis company Avicanna Inc. (TSX: AVCN) (OTC: AVCNF) reported third-quarter revenue of CA$4,943 ($3,737.80), down from CA$35,166 in the same quarter last year. Shared traded up, however, as the company is in a pre-revenue phase, focused on building up is assets, and only started selling its...

Avicanna Inc (TSX: AVCN) (OTC: AVCNF) said Friday its subsidiary Santa Marta Golden Hemp S.A.S. (SMGH) has acquired a United States Department of Agriculture national organic program certification from Control Union Certifications, for its hemp cultivar. It has also attained registration for...

Health Canada has granted biopharmaceutical researcher and cannabis producer Avicanna Inc (TSX: AVCN) with a research license that will allow the company to perform research and intellectual property development on cannabinoids at its facility in the MaRS Discovery District in Toronto. The...

Cannabis researcher and cultivator Avicanna announced a joint venture Thursday with the Canadian full-service testing and research laboratory Sigma Analytical Services Inc. to set up the first cannabis-exclusive analytical facility in South America that Canadian, European, U.S. and EU GMP...

Canadian company Avicanna, a cannabinoid-based products developer, announced Wednesday afternoon it has gained a receipt for its final prospectus filed in connection with its completed special warrant offering for gross proceeds of around C$22.1 million ($16.9 million). The raise was led by Sprott...

Multiple private and public cannabis companies presented their business and outlook to a crowded room during the Benzinga Cannabis Capital Conference April 17-18 in Toronto.  Vertical Companies: Everything But Retail  Vertical Companies is among the largest vertically integrated...

Canada is buzzing after the legalization of recreational cannabis, with long lines at the few retailers already open, a supply shortage, impaired driving fears, people taking to the streets in joy ...  But what does legalization mean for the Canadian economy? How much is the market...

A few months ago, Benzinga visited several countries in South America and subsequently published an article explaining why cannabis investors’ interest in the region, especially in Colombia, was about to spike. In the weeks that followed, numerous U.S. and Canada-based marijuana companies...

A shortened week brought less cannabis news than usual, providing the people in the industry with a chance to exhale and look back at the convoluted weeks leading up to the Fourth of July holiday.  We did witness some relevant action. Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) reported...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

While reporting for a book on the cannabis business I recently finished writing, I realized many people don't differentiate smoking weed from using cannabis. “Isn’t it the same?” is the question I was asked far too often. The answer: certainly not. Smoking is just one of many...

Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...

As a cannabis-focused company, Avicanna did not know what the outcome would be when it applied to be part of JLABS @ Toronto. Yet, the company was delighted to make it, CEO Aras Azadian and LATAM Vice President Lucas Nosiglia told Benzinga in a recent interview. A few things became clear early in...